Medical Device Business — Business Valuation Multiple

Overview

Medical device businesses are valued based on their product portfolio, regulatory approvals, intellectual property, profitability and revenue predictability. Third-party medical device distributors generally attract lower multiples, while contract manufacturers tend to occupy the middle of the valuation range. Manufacturers with proprietary, clinically validated devices can command higher valuations, particularly where an installed device base generates recurring consumable or servicing revenue, such as glucose monitoring sensors, diagnostic test cartridges and insulin pump infusion sets. Established healthcare procurement relationships, diversified customers and proven reimbursement pathways can further support valuations. However, regulatory compliance costs, product liability exposure, clinical development requirements and dependence on a limited number of products or customers can materially reduce multiples. The indicative 4×–9× EBITDA range applies to established, profitable SMEs rather than early-stage or loss-making MedTech companies, which may require alternative valuation methodologies.